The Release of Adipose Stromal Cells from Subcutaneous Adipose Tissue Regulates Ectopic Intramuscular Adipocyte Deposition.

AMD3100 CXCR4/CXCL12 adipose stem or stromal cells chemotaxis ectopic adipocytes intramuscular adipocyte lymphatic system thiazolidinedione type 2 diabetes

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
09 04 2019
Historique:
received: 09 04 2018
revised: 30 12 2018
accepted: 11 03 2019
entrez: 11 4 2019
pubmed: 11 4 2019
medline: 23 6 2020
Statut: ppublish

Résumé

Ectopic lipid deposition (ELD) is defined by excess fat storage in locations not classically associated with adipose tissue (AT) storage. ELD is positively correlated with insulin resistance and increased risk of metabolic disorders. ELD appears as lipid droplets or adipocytes, whose cell origin is unknown. We previously showed that subcutaneous AT (ScAT) releases adipocyte progenitors into the circulation. Here, we demonstrate that triggering or preventing the release of adipocyte precursors from ScAT directly promoted or limited ectopic adipocyte formation in skeletal muscle in mice. Importantly, obesity-associated metabolic disorders could be mimicked by causing adipocyte precursor release without a high-fat diet. Finally, during nutrient overload, adipocyte progenitors exited ScAT, where their retention signals (CXCR4/CXCL12 axis) were greatly decreased, and further infiltrated skeletal muscles. These data provide insights into the formation of ELD associated with calorie overload and highlight adipocyte progenitor trafficking as a potential target in the treatment of metabolic diseases.

Identifiants

pubmed: 30970240
pii: S2211-1247(19)30354-7
doi: 10.1016/j.celrep.2019.03.038
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-333.e5

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Amandine Girousse (A)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France. Electronic address: amandine.girousse@inserm.fr.

Marta Gil-Ortega (M)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Virginie Bourlier (V)

Institut des maladies métaboliques et cardiovasculaires, Team 4, UMR1048, Université Paul Sabatier, 31432 Toulouse, France.

Célia Bergeaud (C)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Quentin Sastourné-Arrey (Q)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Cédric Moro (C)

Institut des maladies métaboliques et cardiovasculaires, Team 4, UMR1048, Université Paul Sabatier, 31432 Toulouse, France.

Corinne Barreau (C)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Christophe Guissard (C)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Julie Vion (J)

Institut des maladies métaboliques et cardiovasculaires, Team 4, UMR1048, Université Paul Sabatier, 31432 Toulouse, France.

Emmanuelle Arnaud (E)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Jean-Philippe Pradère (JP)

Institut des maladies métaboliques et cardiovasculaires, Team 3, UMR1048, Université Paul Sabatier, 31432 Toulouse, France.

Noémie Juin (N)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Louis Casteilla (L)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France.

Coralie Sengenès (C)

Stromalab, Université de Toulouse, CNRS ERL5311, EFS, INP-ENVT, INSERM U1031, Université Paul Sabatier, 31432 Toulouse, France. Electronic address: coralie.sengenes@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH